KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $32.48 million. The enterprise value is $15.09 million.

Market Cap	32.48M
Enterprise Value	15.09M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 4.61 million shares outstanding. The number of shares has increased by 46.80% in one year.

Current Share Class	4.61M
Shares Outstanding	4.61M
Shares Change (YoY)	+46.80%
Shares Change (QoQ)	+7.71%
Owned by Insiders (%)	3.91%
Owned by Institutions (%)	15.80%
Float	2.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.36
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.07, with a Debt / Equity ratio of 2.68.

Current Ratio	3.07
Quick Ratio	2.84
Debt / Equity	2.68
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.06

Financial Efficiency

Return on equity (ROE) is -248.11% and return on invested capital (ROIC) is -50.77%.

Return on Equity (ROE)	-248.11%
Return on Assets (ROA)	-40.25%
Return on Capital (ROIC)	-50.77%
Revenue Per Employee	n/a
Profits Per Employee	-$900,395
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.71% in the last 52 weeks. The beta is -2.14, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.14
52-Week Price Change	+0.71%
50-Day Moving Average	5.86
200-Day Moving Average	6.60
Relative Strength Index (RSI)	67.29
Average Volume (20 Days)	22,295

Short Selling Information

The latest short interest is 29,281, so 0.64% of the outstanding shares have been sold short.

Short Interest	29,281
Short Previous Month	29,892
Short % of Shares Out	0.64%
Short % of Float	1.05%
Short Ratio (days to cover)	2.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.25M
Pretax Income	-38.72M
Net Income	-38.72M
EBITDA	-40.98M
EBIT	-41.25M
Earnings Per Share (EPS)	-$13.94

Full Income Statement

Balance Sheet

The company has $54.20 million in cash and $36.80 million in debt, giving a net cash position of $17.40 million or $3.78 per share.

Cash & Cash Equivalents	54.20M
Total Debt	36.80M
Net Cash	17.40M
Net Cash Per Share	$3.78
Equity (Book Value)	13.72M
Book Value Per Share	2.98
Working Capital	39.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.71 million and capital expenditures -$337,000, giving a free cash flow of -$31.04 million.

Operating Cash Flow	-30.71M
Capital Expenditures	-337,000
Free Cash Flow	-31.04M
FCF Per Share	-$6.74

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.80%
Shareholder Yield	-46.80%
Earnings Yield	-119.19%
FCF Yield	-95.57%

Analyst Forecast

The average price target for KALA BIO is $16.50, which is 134.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.50
Price Target Difference	134.04%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2